United States Vital Signs Monitoring Devices Market 2033 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The global vital signs monitoring devices market reached US$ 5.35 Billion in 2023, with a rise of US$ 5.73 Billion in 2024 and is expected to reach US$ 11.12 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/vital-signs-monitoring-devices-market?sb

Key Development:

United States: Recent Industry Developments

✅ In January 2026, FaceHeart received FDA 510(k) clearance for its contactless video-based vital sign measurement SDK, enabling heart rate, respiration, blood pressure, SpO2 and other vitals to be captured via smartphone cameras this unique contact-free technology expands how vital signs can be monitored in telehealth and preventive care settings.

✅ In January 2026, Dexcom began wider pharmacy distribution of its G7 15-Day continuous glucose monitoring system, increasing access to extended vital sign tracking for metabolic health outside traditional clinical channels signaling broader availability of advanced sensor-based monitoring in real-world care.

✅ In December 2025, industry reports noted accelerated commercialization and capacity announcements across U.S. vital signs monitoring vendors, highlighting broader product launches and deployments targeting remote patient monitoring and hospital use cases reflecting momentum in multi-parameter monitoring solutions.

✅ In December 2025, Ceribell achieved multiple FDA regulatory milestones for its neurological monitoring solutions, including 510(k) clearances and Breakthrough Device Designation for stroke detection technology that supports vital sign-related clinical evaluation workflows underscoring regulatory progress in adjacent monitoring tech.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=vital-signs-monitoring-devices-market

Japan: Recent Industry Developments

✅ In January 2026, Huawei Japan's HUAWEI WATCH D2 wearable with integrated medical-grade blood pressure monitoring and ECG functions reached significant crowdfunding milestones in Japan and prepares for broader commercial availability, blending vital sign tracking with consumer wearables marking a major device launch for vitals tracking.

✅ In December 2025, HUAWEI WATCH D2 smart wearable hosting advanced automatic blood pressure monitoring functionality was showcased at product briefings in Japan, enhancing continuous vital sign measurement capabilities for everyday users driving adoption of integrated monitoring tech in the Japanese market.

✅ In December 2025, Omron Healthcare strengthened collaboration and investment with Sky Labs on cuff-less blood pressure device technology, signaling increased R&D and partnership activity in Japan's vital signs device ecosystem reflecting industry commitment to next-gen monitoring solutions.

✅ In December 2025, Omron developed an AI model using large-scale home blood pressure data to predict measurement continuity, highlighting advanced analytics integration into vital sign devices and reinforcing product evolution in the Japanese healthcare market showing tech progress beyond hardware.

Key Players:

=> Koninklijke Philips N.V., Medtronic Nihon Kohden Corporation, GE Healthcare, Masimo Corporation, Omron Healthcare, Contec Medical Systems Co., Ltd., A&D Company Ltd., Nonin Medical Inc., and SunTech Medical, Inc., among others.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/vital-signs-monitoring-devices-market?sb

Key Segments:

By Product Type

Temperature Monitoring Devices lead with 35% share, driven by critical patient monitoring, infection control, and growing demand in hospitals, clinics, and home care. Pulse Oximeters account for 30%, supported by respiratory care, COVID-19 monitoring, and widespread adoption in both clinical and home settings. Blood Pressure Monitoring Devices hold 35%, fueled by increasing prevalence of cardiovascular diseases, hypertension awareness, and preventive healthcare initiatives.

By Application

Cardiology dominates with 30% share, reflecting high demand for continuous blood pressure and pulse monitoring in hospitals and clinics. Respiratory Care accounts for 25%, driven by adoption of pulse oximeters and temperature devices for chronic and acute respiratory conditions. Neurology represents 10%, supported by patient monitoring in neurodegenerative and critical care conditions. Pediatric Care holds 15%, fueled by specialized devices for infant and child health monitoring. Emergency Care accounts for 15%, reflecting high utilization in ambulances, emergency departments, and urgent care centers. Others make up 5%, including general patient monitoring, wellness, and remote care.

By End User

Hospitals and Clinics dominate with 50% share, driven by high patient volumes, surgical procedures, and intensive care monitoring. Diagnostic Centers hold 20%, supported by outpatient testing and specialized health assessments. Home Care Settings account for 15%, fueled by remote patient monitoring and chronic disease management. Ambulatory Surgical Centers represent 10%, reflecting minor surgical and outpatient procedures. Other Healthcare Settings make up 5%, including nursing homes, rehabilitation centers, and telehealth facilities.

By Region

North America - 35% Share
North America leads with 35%, driven by advanced healthcare infrastructure, rising chronic disease prevalence, and strong adoption of remote and in-hospital patient monitoring devices in the U.S. and Canada.

Europe - 25% Share
Europe holds 25%, supported by aging populations, robust healthcare systems, and high adoption of medical monitoring devices in Germany, France, U.K., Italy, Spain, and neighboring countries.

Asia Pacific - 30% Share
Asia Pacific accounts for 30%, fueled by expanding healthcare infrastructure, growing awareness of cardiovascular and respiratory health, and rising homecare adoption in China, India, Japan, South Korea, and Southeast Asia.

Middle East & Africa - 5% Share
The Middle East & Africa represent 5%, driven by improving healthcare services, increasing investment in medical infrastructure, and rising telehealth adoption in GCC countries and South Africa.

South America - 5% Share
South America holds 5%, supported by emerging healthcare facilities, increased awareness of chronic diseases, and growing adoption of monitoring devices in Brazil, Mexico, and neighboring regions.

FAQ

What is the current size of the Vital signs monitoring devices Market?

A: In 2024, the Vital signs monitoring devices Market was valued at US$ 5.73 Billion , reflecting its strong industry presence.

Q2: How large is the Vital signs monitoring devices Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Vital signs monitoring devices Market will grow to around US$ 11.12 Billion, demonstrating significant expansion.

Q3: What is the growth rate of the Vital signs monitoring devices Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 7.7% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.